Ling Zhong

1.2k total citations
38 papers, 708 citations indexed

About

Ling Zhong is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Ling Zhong has authored 38 papers receiving a total of 708 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 10 papers in Cancer Research and 7 papers in Surgery. Recurrent topics in Ling Zhong's work include Breast Cancer Treatment Studies (5 papers), Genomics and Phylogenetic Studies (3 papers) and Nuclear Receptors and Signaling (3 papers). Ling Zhong is often cited by papers focused on Breast Cancer Treatment Studies (5 papers), Genomics and Phylogenetic Studies (3 papers) and Nuclear Receptors and Signaling (3 papers). Ling Zhong collaborates with scholars based in China, United States and Taiwan. Ling Zhong's co-authors include Shao‐Jun Tang, Xiangling Yang, Bei Li, Yichen Li, Wei Zhang, Jun Jiang, Min Huang, Tommy Andersson, Bei Li and Yanxi Peng and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Journal of Neuroscience.

In The Last Decade

Ling Zhong

34 papers receiving 700 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ling Zhong China 15 334 153 143 122 122 38 708
Zhitao Han China 15 425 1.3× 245 1.6× 139 1.0× 84 0.7× 137 1.1× 30 822
Dan Chen China 14 406 1.2× 159 1.0× 81 0.6× 176 1.4× 76 0.6× 47 1.1k
Ching‐Chi Chiu Taiwan 20 538 1.6× 155 1.0× 89 0.6× 140 1.1× 117 1.0× 32 1.1k
Wei‐Bing Xie China 20 509 1.5× 134 0.9× 204 1.4× 105 0.9× 110 0.9× 41 1.0k
Gianluca Figlia Germany 15 475 1.4× 127 0.8× 255 1.8× 86 0.7× 91 0.7× 17 847
Bruna Barneda‐Zahonero Spain 15 732 2.2× 82 0.5× 158 1.1× 139 1.1× 111 0.9× 23 1.0k
Lin Zou China 19 509 1.5× 96 0.6× 137 1.0× 113 0.9× 224 1.8× 73 1.1k
Valentina Caracciolo United States 13 527 1.6× 133 0.9× 56 0.4× 179 1.5× 224 1.8× 21 985

Countries citing papers authored by Ling Zhong

Since Specialization
Citations

This map shows the geographic impact of Ling Zhong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling Zhong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling Zhong more than expected).

Fields of papers citing papers by Ling Zhong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ling Zhong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling Zhong. The network helps show where Ling Zhong may publish in the future.

Co-authorship network of co-authors of Ling Zhong

This figure shows the co-authorship network connecting the top 25 collaborators of Ling Zhong. A scholar is included among the top collaborators of Ling Zhong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ling Zhong. Ling Zhong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Shengke, Min Wang, Yilei Wu, et al.. (2025). Emergence and global spread of a dominant multidrug-resistant clade within Acinetobacter baumannii. Nature Communications. 16(1). 2787–2787. 11 indexed citations
2.
Chen, Cheng, et al.. (2025). Hyaluronanized gold nanoparticles functionalized with CTX-II antibody for early diagnosis and treatment of knee osteoarthritis. Chemical Engineering Journal. 506. 160078–160078. 2 indexed citations
3.
Wu, Ming-Hung, et al.. (2025). Emotion recognition in panoramic audio and video virtual reality based on deep learning and feature fusion. Egyptian Informatics Journal. 30. 100697–100697.
4.
Li, Weiwei, Zun-hua Chu, Nian X. Sun, et al.. (2025). Prevalence, bacterial load, and genomic characterization of Vibrio parahaemolyticus in freshwater-farmed Litopenaeus vannamei from China. Frontiers in Microbiology. 16. 1713237–1713237.
5.
Liu, Yi, Yifan Zhan, Jiao Liu, et al.. (2024). The 7-Methylguanosine (m7G) methylation METTL1 acts as a potential biomarker of clear cell renal cell carcinoma progression. Translational Oncology. 51. 102202–102202. 1 indexed citations
6.
Chen, Binbin, Liang Yu, Guoli Sun, et al.. (2024). A real-world, cross-sectional, and longitudinal study on high-risk human papillomavirus genotype distribution in 31,942 women in Dongguan, China. Frontiers in Public Health. 12. 1409030–1409030. 1 indexed citations
7.
Yao, Li, Xiang Cui, Yongjun Yang, et al.. (2019). Serum sPD-1 and sPD-L1 as Biomarkers for Evaluating the Efficacy of Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer Patients. Clinical Breast Cancer. 19(5). 326–332.e1. 33 indexed citations
8.
Zhong, Ling, Guangneng Liao, Xiaojiao Wang, et al.. (2018). Mesenchymal stem cells–microvesicle-miR-451a ameliorate early diabetic kidney injury by negative regulation of P15 and P19. Experimental Biology and Medicine. 243(15-16). 1233–1242. 40 indexed citations
10.
Wu, Xiujuan, Peng Tang, Shifei Li, et al.. (2018). A randomized and open-label phase II trial reports the efficacy of neoadjuvant lobaplatin in breast cancer. Nature Communications. 9(1). 832–832. 37 indexed citations
11.
Qi, Xiaowei, Junze Du, Peng Tang, et al.. (2018). Clinical significance of internal mammary lymph node metastasis for breast cancer: Analysis of 337 breast cancer patients. Surgical Oncology. 27(2). 185–191. 16 indexed citations
12.
Jiang, Tao, et al.. (2018). miR-451a induced apoptosis of Philadelphia chromosome-positive acute lymphoblastic leukemia cells by targeting IL-6R. Neoplasma. 65(6). 907–914. 6 indexed citations
13.
Qi, Xiaowei, Fan Zhang, Xinhua Yang, et al.. (2012). High Wilms’ tumor 1 mRNA expression correlates with basal-like and ERBB2 molecular subtypes and poor prognosis of breast cancer. Oncology Reports. 28(4). 1231–1236. 27 indexed citations
14.
Peng, Yanxi, et al.. (2012). A Role of the Mammalian Target of Rapamycin (mTOR) in Glutamate-Induced Down-regulation of Tuberous Sclerosis Complex Proteins 2 (TSC2). Journal of Molecular Neuroscience. 47(2). 340–345. 10 indexed citations
15.
16.
Li, Bei, et al.. (2012). Activation of NMDA Receptors Upregulates A Disintegrin and Metalloproteinase 10 via a Wnt/MAPK Signaling Pathway. Journal of Neuroscience. 32(11). 3910–3916. 61 indexed citations
17.
Yang, Xiangling, et al.. (2011). Effects of conjugated linoleic acid on cleavage of amyloid precursor protein via PPARγ. Neurological Sciences. 32(6). 1095–1101. 10 indexed citations
18.
Qi, Xiaowei, Fan Zhang, Xinhua Yang, et al.. (2010). Transforming growth factor-β1 polymorphisms and breast cancer risk: a meta-analysis based on 27 case–control studies. Breast Cancer Research and Treatment. 122(1). 273–279. 16 indexed citations
19.
Guan, Liping, Jie Yu, Ling Zhong, et al.. (2010). Biological safety of human skin-derived stem cells after long-term in vitro culture. Journal of Tissue Engineering and Regenerative Medicine. 5(2). 97–103. 21 indexed citations
20.
Li, Hongliang, et al.. (2002). JTE-522, a selective COX-2 inhibitor, inhibits cell proliferation and induces apoptosis in RL95-2 cells.. PubMed. 23(7). 631–7. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026